AISLING CAPITAL LLC
CRD #157698 SEC #802-74394 NEW YORK, NY 212-651-6380
State Registered Exempt Reporting Private Funds
Total AUM
--
Discretionary
--
Employees
--
Clients
--
Accounts
--
| Fund Name | Type | GAV | Investors | Auditor |
|---|---|---|---|---|
| AISLING CAPITAL III, LP | Venture Capital Fund | $705.2M | 59 | COHNREZNICK LLP |
| AISLING CAPITAL III, LP | Venture Capital Fund | $608.8M | 59 | COHNREZNICK LLP |
| AISLING CAPITAL III, LP | Venture Capital Fund | $586.2M | 59 | COHNREZNICK LLP |
| AISLING CAPITAL II, LP | Venture Capital Fund | $450.8M | 62 | COHNREZNICK LLP |
| AISLING CAPITAL II, LP | Venture Capital Fund | $413.5M | 62 | COHNREZNICK LLP |
| AISLING CAPITAL II, LP | Venture Capital Fund | $392.1M | 62 | COHNREZNICK LLP |
| PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP | Venture Capital Fund | $109.2M | 16 | COHNREZNICK LLP |
| PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP | Venture Capital Fund | $68M | 16 | COHNREZNICK LLP |
| AISLING CAPITAL II, LP | Venture Capital Fund | $53M | 65 | COHNREZNICK LLP |
| PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP | Venture Capital Fund | $30M | 16 | COHNREZNICK LLP |
| AISLING CAPITAL III, LP | Venture Capital Fund | $11M | 57 | COHNREZNICK LLP |
TypeVenture Capital Fund
GAV$109.2M
Investors16
AuditorCOHNREZNICK LLP
TypeVenture Capital Fund
GAV$68M
Investors16
AuditorCOHNREZNICK LLP
TypeVenture Capital Fund
GAV$30M
Investors16
AuditorCOHNREZNICK LLP